The Role of Nutrients on The Treatment of Sarcopenia and Muscles Across Age

Special Article: Dementia

Gerontol Geriatr Res. 2024; 10(1): 1098.

The Role of Nutrients on The Treatment of Sarcopenia and Muscles Across Age

Samer Yones*

Department of Pharmacy, Tartous University, Syria

*Corresponding author: Samer Yones Department of Pharmacy, Tartous University, Syria. Email: yonessamer22@gmail.com

Received: April 12, 2024 Accepted: May 07, 2024 Published: May 14, 2024

Abstract

Sarcopenia is a degenerative skeletal muscle condition associated with aging, resulting in muscle mass and function decline. It has been connected to inflammation, oxidative stress, insulin resistance, hormonal changes, and impaired muscle satellite cell activation. The gut microbiome is crucial for muscle health, and supplements like probiotics, prebiotics, protein, creatine, and beta-alanine can aid muscle growth and function while supporting gut health. Chronic low-grade inflammation is a primary cause of sarcopenia, activating pathways leading to muscle wasting and reduced protein synthesis. Insulin resistance, hormonal changes, impaired muscle satellite cell activation, and high fat mass levels also contribute to sarcopenia development. Resistance exercise and dietary supplements have proven effective in treating sarcopenia. Furthermore, a combination of resistance exercise and supplementation has shown to have a more significant positive impact on anthropometric and muscle function parameters, reducing the sarcopenic state. Therefore, understanding the gut microbiome’s role in muscle metabolism is essential for developing new sarcopenia treatments for all age groups.

Keywords: Nutrients supplements; Sarcopenia; Muscle mass

Introduction

Sarcopenia is a multifaceted age-related condition influenced by various mechanisms that result in decreased muscle strength and function due to impaired muscle synthesis and increased muscle catabolism [1]. These mechanisms include inflammation, oxidative stress, insulin resistance, hormonal changes, and inhibited activation of muscle satellite cells, among others, which are considered pivotal factors in the development and progression of sarcopenia [2,3]. Nutritional status plays a significant role in maintaining muscle structure and metabolism in individuals with sarcopenia, as chronic inflammation has been associated with both muscle dysfunction and gut metabolism [4]. Certain supplements, such as omega-3 fatty acids, have been shown to reduce systemic inflammatory markers and support gut and muscle health. The structure of the gut and changes in microbiota are closely linked to human health and disease as individuals age. Nutritional supplements containing essential nutrients can play a crucial role in promoting gut and muscle health [5-8]. For instance, probiotics and prebiotics can help maintain a healthy gut microbiome by fostering the growth of beneficial gut bacteria and enhancing gut microbial diversity [9]. Moreover, specific nutrients like protein, creatine, and beta-alanine have demonstrated benefits in supporting muscle growth and function. Furthermore, a recent study indicated that supplementing to restore gut balance in critically ill patients can lead to a shorter stay in the Intensive Care Unit (ICU), reduced muscle protein breakdown, and decreased complications from infections [10]. m,kij78y6Furthermore, a recent systematic analysis indicated that the gut microbiota could have a notable impact on muscle balance through the gut-muscle connection. Consequently, comprehending the correlation between gut microbiota and muscle function is crucial for the advancement of novel therapies for conditions like sarcopenia, particularly in different age groups [11].

Methods

We conducted a review by searching the Google Scholar, PubMed, and Directory Open access Journal databases for relevant information using keywords such as Nutrients, muscle mass, Nutrition, nutrient supplements, sarcopenia, microbiota, muscle strength, Insulin, Insulin resistance, vitamins, micronutrients, vitamins supplements, to identify primary comparative studies on treatment and management options for sarcopenia. The quality and strength levels of the results were considered and when available meta-analyses and systematic reviews, large epidemiological studies and randomized control trials represented the main source of data.

Results

Sarcopenia

Sarcopenia, a prevalent condition among the elderly, is a progressive disorder characterized by the loss of muscle mass and function. This condition is associated with various negative outcomes, including an increased risk of falls, functional decline, frailty, and mortality in older populations [12]. The European Working Group on Sarcopenia in Older People (EWGSOP) has established specific criteria for diagnosing sarcopenia, which involves assessing muscle mass, muscle strength, and physical performance using various measurement techniques [13-15]. Chronic low-grade inflammation has been identified as a potential mechanism contributing to muscle wasting in sarcopenia, as it can activate signaling pathways that lead to muscle degradation and reduce muscle protein synthesis [15]. Additionally, oxidative stress and insulin resistance have also been implicated in the development of sarcopenia, as they can disrupt the balance between muscle protein synthesis and degradation. Hormonal changes, such as decreased testosterone levels in men and decreased estrogen levels in women, may further contribute to sarcopenia by reducing muscle protein synthesis and increasing muscle protein degradation. Furthermore, the impaired activation of muscle satellite cells with aging can lead to decreased muscle repair and increased muscle wasting [3,12]. Body composition, specifically the presence of excess fat mass, has also been linked to sarcopenia, as studies have shown that increased fat mass is associated with decreased muscle mass and strength in older adults. This inverse relationship between fat mass and muscle mass may partially explain the pathogenesis of sarcopenia [16,17] (Figure 1 & 2).

Citation: Yones S. The Role of Nutrients on The Treatment of Sarcopenia and Muscles Across Age. Gerontol Geriatr Res. 2024; 10(1): 1098.